Advertisement
Screener

INNOVUS PHARMACEUTICALS, INC. Accounts Receivable

INNOVUS PHARMACEUTICALS, INC. Accounts Receivable

INNOVUS PHARMACEUTICALS, INC. had Accounts Receivable of $117.00 thousand as of 2019-09-30, per its 10-Q filed 2019-11-14.

Discontinued › Balance Sheet › Assets › Assets, Current

us-gaap:AccountsReceivableNetCurrent · last filed 2019-11-14

  • 2019-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $117.00K.
  • 2019-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $319.00K.
  • 2019-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $130.00K.
  • 2018-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $282.00K.
Period endAccounts Receivable, after Allowance for Credit Loss, CurrentAccounts Receivable, after Allowance for Credit Loss, Current as first filed
2019-09-30$117.00K
10-Q · filed 2019-11-14
2019-06-30$319.00K
10-Q · filed 2019-08-13
2019-03-31$130.00K
10-Q · filed 2019-05-15
2018-12-31$282.00K
10-Q · filed 2019-11-14
2018-09-30$356.35K
10-Q · filed 2018-11-14
2018-06-30$287.35K
10-Q · filed 2018-08-14
2018-03-31$195.24K
10-Q · filed 2018-05-14
2017-12-31$68.00K
10-K · filed 2019-04-01
$68.26K
10-K · filed 2018-04-02
2017-09-30$27.53K
10-Q · filed 2017-11-14
2017-06-30$21.15K
10-Q · filed 2017-08-14
2017-03-31$15.07K
10-Q · filed 2017-05-15
2016-12-31$33.58K
10-K · filed 2018-04-02
2016-09-30$30.88K
10-Q · filed 2016-11-14
2016-06-30$22.15K
10-Q · filed 2016-08-15
2016-03-31$45.18K
10-Q · filed 2016-05-16
2015-12-31$83.10K
10-K · filed 2017-03-09
2015-09-30$68.23K
10-Q · filed 2015-11-16
2015-06-30$37.88K
10-Q · filed 2015-08-14
2015-03-31$81.15K
10-Q · filed 2015-05-15
2014-12-31$191.60K
10-K · filed 2016-03-30
2014-09-30$428.32K
10-Q · filed 2014-11-14
2014-06-30$153.13K
10-Q · filed 2014-08-14
2014-03-31$210.87K
10-Q · filed 2014-05-14
2013-12-31$216.64K
10-K · filed 2015-03-31
2013-09-30$75.17K
10-Q · filed 2013-11-14
2013-06-30$280.00
10-Q · filed 2013-08-13
2012-12-31$0.00
10-K · filed 2014-03-28